homocysteine has been researched along with Atrial Fibrillation in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.88) | 18.2507 |
2000's | 17 (41.46) | 29.6817 |
2010's | 13 (31.71) | 24.3611 |
2020's | 9 (21.95) | 2.80 |
Authors | Studies |
---|---|
Margolin, E; Nicholson, P; Patel, TJ; Zaslavsky, K | 1 |
Hidru, TH; Li, D; Wang, N; Wang, S; Wang, Y; Wei, Y; Xia, Y; Yang, X; Yang, Y | 1 |
Bang, OY; Choi, JC; Choi, KH; Chung, JW; Heo, SH; Hwang, YH; Jung, JM; Kim, BJ; Kim, CK; Kim, GM; Kim, JM; Kim, JT; Kim, YJ; Nam, KW; Oh, K; Park, JH; Park, KY; Park, MS; Seo, WK; Song, TJ; Yu, S | 1 |
Chen, X; Han, L; Hong, K; Li, J; Li, S; Tang, Y; Wu, Q; Wu, Y | 1 |
Wang, L; Zhang, Y | 1 |
Hong, J; Hu, J; Huang, L; Jin, N; Pu, J; Rong, H; Wang, S; Xie, Y | 1 |
Azarpazhooh, MR; Bogiatzi, C; Hankey, GJ; Larsson, SC; Spence, JD | 1 |
Lu, Y; Sun, X; Wang, Q; Wang, Z; Zheng, L | 1 |
Chen, KP; Chen, LJ; Dong, XJ; Guo, JW; Hou, FF; Liu, XL; Sun, X; Wang, BB; Zhou, HD | 1 |
Dong, JZ; Du, X; Gao, LJ; Hu, R; Jiang, CX; Liu, T; Long, DY; Lv, Q; Ning, M; Shang, MS; Tang, RB; Yang, XH; Yao, Y; Zhao, JH; Zhu, H | 1 |
Dong, JZ; Ma, CS; Shang, MS; Yao, Y | 1 |
Alonso, A; Folsom, AR; Heckbert, SR; Kubota, Y; Norby, FL | 1 |
Inoue, S; Shibata, Y; Watanabe, M | 1 |
Kilicaslan, F; Ozmen, N; Tokatli, A; Uzun, M; Yiginer, O | 1 |
Dolgoshey, TS; Doroshenko, EM; Rubinsky, AY; Smirnov, VY; Snezhitsky, VA; Yatskevich, ES | 1 |
Bai, R; Dong, JZ; Du, X; Jiang, CX; Liu, XH; Long, DY; Lu, ZH; Ma, CS; Sang, CH; Tang, RB; Yao, W; Yao, Y; Yu, RH; Zhang, JQ | 1 |
Spence, JD | 1 |
Inden, Y; Kamiya, H; Murohara, T; Shibata, R; Shimano, M; Tsuji, Y; Uchikawa, T | 1 |
Van Wagoner, DR | 1 |
Allen, CL; Bayraktutan, U | 1 |
McLachlan, CS; Mossop, P; Ravasini, JA | 1 |
Spence, D | 1 |
Kharche, S; Law, P; Stott, J; Zhang, H | 1 |
Liebeskind, DS; Ovbiagele, B; Pineda, S; Saver, JL | 1 |
Kanic, V; Naji, F; Sabovic, M; Suran, D; Vokac, D | 1 |
Sarnak, MJ; Shastri, S | 1 |
Bartolomucci, F; Bonifazi, R; Brigiani, MS; Fattouch, K; Fiore, F; Gaudino, M; Gaudio, C; Lamarra, M; Nasso, G; Romano, V; Rosano, G; Speziale, G; Spirito, R | 1 |
Cebeci, BS; Cingozbay, BY; Demiralp, E; Dincturk, M; Kardesoglu, E; Yiginer, O | 1 |
Arsava, EM; Ay, H; Ozer, N; Saribas, O; Tokgözoglu, SL | 1 |
Boysen, G; Brander, T; Christensen, H; Gideon, R; Truelsen, T | 1 |
Blann, A; Lip, GY; Nadar, S | 1 |
Lip, GY; Nadar, S | 1 |
Cases, A | 1 |
Cangemi, R; D'Angelo, A; Di Lecce, VN; Fimognari, FL; Loffredo, L; Mazzola, G; Sampietro, F; Sbrighi, PS; Violi, F | 1 |
Abbate, R; Antonucci, E; Cecchi, E; Cellai, AP; Gensini, GF; Lenti, M; Liotta, AA; Marcucci, R; Poli, D; Prisco, D | 1 |
Bai, YL; Cai, BZ; Gong, DM; Liu, Y; Lu, YJ; Pan, ZW; Qiao, GF; Xu, CQ; Yang, BF | 1 |
Gunby, P | 1 |
Wolf, PA | 1 |
Breteler, MM | 1 |
Friedman, HS | 1 |
8 review(s) available for homocysteine and Atrial Fibrillation
Article | Year |
---|---|
Elevated Homocysteine Levels Associated with Atrial Fibrillation and Recurrent Atrial Fibrillation.
Topics: Atrial Fibrillation; Case-Control Studies; Homocysteine; Humans; Hyperhomocysteinemia; Recurrence; Risk Assessment; Software | 2020 |
Stroke Prevention in Older Adults: Recent Advances.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carotid Stenosis; Dementia; Diet; Diet, Vegetarian; Endarterectomy, Carotid; Ezetimibe; Factor Xa Inhibitors; Gastrointestinal Microbiome; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Patient Care Planning; Patient Selection; Platelet Aggregation Inhibitors; Renal Insufficiency; Stents; Stroke; Vascular Stiffness; Vitamin B Complex | 2020 |
Homocysteine (HCY) levels in patients with atrial fibrillation (AF): A meta-analysis.
Topics: Atrial Fibrillation; Female; Heart Failure; Homocysteine; Humans; Risk Factors | 2021 |
Homocysteine in non-valvular atrial fibrillation: Role and clinical implications.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Biomarkers; Female; Heart Atria; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress; Risk Factors; Sex Factors; Stroke; Thromboembolism | 2017 |
Impact of reduced pulmonary function in the Japanese general population: Lessons from the Yamagata-Takahata study.
Topics: Adiponectin; Asian People; Atrial Fibrillation; Biomarkers; Cigarette Smoking; Comorbidity; Diabetes Mellitus; Female; Homocysteine; Humans; Japan; Lung; Male; Metabolic Syndrome; Physical Examination; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Risk Factors; Spirometry; Uric Acid | 2019 |
Risk factors for ischaemic stroke.
Topics: Aging; Atherosclerosis; Atrial Fibrillation; Brain Ischemia; Heart Failure; Homocysteine; Humans; Hypertension; Leukocyte Count; Risk Factors; Stroke; Waist-Hip Ratio | 2008 |
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
Prevention of stroke.
Topics: Anticholesteremic Agents; Anticoagulants; Atrial Fibrillation; Carotid Stenosis; Cerebrovascular Disorders; Cholesterol, LDL; Exercise; Folic Acid; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Patient Selection; Smoking Cessation | 1998 |
1 trial(s) available for homocysteine and Atrial Fibrillation
Article | Year |
---|---|
Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation.
Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; Female; Homocysteine; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2008 |
32 other study(ies) available for homocysteine and Atrial Fibrillation
Article | Year |
---|---|
Hypercoagulability in patients with indirect carotid cavernous fistulas.
Topics: Antibodies, Anticardiolipin; Antithrombin III; Atrial Fibrillation; Female; Fibrinogen; Fistula; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Protein C; Prothrombin; Thrombophilia | 2022 |
Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation.
Topics: Atrial Fibrillation; Female; Homocysteine; Humans; Male; Pacemaker, Artificial; Risk Factors; Uric Acid | 2022 |
Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Homocysteine; Humans; Ischemic Stroke; Kidney Diseases; Male; Prospective Studies; Risk Factors; Stroke | 2022 |
Protective mechanism of SIRT1 on Hcy-induced atrial fibrosis mediated by TRPC3.
Topics: Acetylcholine; Animals; Animals, Newborn; Aorta; Atrial Fibrillation; Cardiotonic Agents; Cell Differentiation; Cell Line; Cell Proliferation; Constriction, Pathologic; Electrocardiography; Female; Fibroblasts; Fibrosis; Heart Atria; Homocysteine; Humans; Male; Mice, Inbred C57BL; Middle Aged; Protein Binding; Sinoatrial Node; Sirtuin 1; Stroke Volume; TRPC Cation Channels | 2020 |
Role of hyperhomocysteine, thyroid dysfunction and their interaction in ischemic stroke patients with non-valvular atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypothyroidism; Ischemic Stroke; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Thyroid Gland; Thyrotropin | 2020 |
No causal association between plasma homocysteine levels and atrial fibrillation: A Mendelian randomization study.
Topics: Atrial Fibrillation; Biomarkers; Genetic Predisposition to Disease; Genome-Wide Association Study; Homocysteine; Humans; Hyperhomocysteinemia; Mendelian Randomization Analysis; Meta-Analysis as Topic; Phenotype; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors | 2021 |
Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score.
Topics: Aged; Atrial Appendage; Atrial Fibrillation; Biomarkers; Cross-Sectional Studies; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prognosis; Registries; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation | 2018 |
[Research progress on the correlation between hmocysteine and atrial fibrilation].
Topics: Atrial Fibrillation; Female; Heart Atria; Homocysteine; Humans; Male | 2017 |
Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Atrial Fibrillation; Biomarkers; Ethnicity; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Population Surveillance; Prognosis; Prospective Studies; Risk Assessment; Risk Factors | 2019 |
Paroxysmal atrial fibrillation and related thromboembolism may be a hidden factor in the development of dementia.
Topics: Atrial Fibrillation; Dementia; Homocysteine; Humans; Thromboembolism | 2016 |
[HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Coronary Artery Disease; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Statistics as Topic | 2016 |
Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation.
Topics: Aged; Area Under Curve; Atrial Fibrillation; Biomarkers; Catheter Ablation; Chi-Square Distribution; China; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Recurrence; Reproducibility of Results; Risk Factors; ROC Curve; Time Factors; Treatment Outcome; Up-Regulation | 2017 |
Increased Coagulation With Aging: Importance of Homocysteine and Vitamin B12.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Thrombophilia; Vitamin B 12 | 2017 |
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
Topics: Atrial Fibrillation; Biomarkers; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Ventricular Dysfunction, Left | 2008 |
Homocysteine and heavy metal interactions in atrial fibrillation and ablation treatments.
Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; Female; Homocysteine; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Mechanisms of thrombogenesis in atrial fibrillation.
Topics: Atrial Fibrillation; Blood Coagulation Factors; Homocysteine; Humans; Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency | 2009 |
Effects of elevated Homocysteine hormone on electrical activity in the human atrium: A simulation study.
Topics: Action Potentials; Algorithms; Arrhythmias, Cardiac; Atrial Fibrillation; Biophysics; Computer Simulation; Electric Conductivity; Electrophysiology; Gap Junctions; Heart Atria; Homocysteine; Humans; Models, Anatomic; Potassium Channels; Time Factors | 2009 |
Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack.
Topics: Atrial Fibrillation; Biomarkers; Brain; Cerebral Arteries; Cerebral Hemorrhage; Cross-Sectional Studies; Diffusion Magnetic Resonance Imaging; Female; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Proteinuria; Risk Factors; Sex Distribution; Stroke | 2010 |
High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion.
Topics: Aged; Atrial Fibrillation; Electric Countershock; Female; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies | 2010 |
Cardiovascular disease and CKD: core curriculum 2010.
Topics: Acute Coronary Syndrome; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Catheterization; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Diabetic Nephropathies; Dyslipidemias; Electrocardiography; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Life Style; Myocardial Ischemia; Oxidative Stress; Pericarditis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Smoking; Troponin T | 2010 |
Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation.
Topics: Aged; Area Under Curve; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography, Ambulatory; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; ROC Curve; Thoracotomy; Time Factors; Treatment Outcome; Up-Regulation | 2013 |
Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrilation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Stroke; Thromboembolism | 2002 |
Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Stroke; Thrombosis | 2003 |
Homocysteine and risk of recurrent stroke.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Denmark; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Prospective Studies; Recurrence; Risk; Risk Factors; Smoking; Stroke | 2003 |
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk; Thromboembolism; Thrombophilia; Ventricular Dysfunction, Left | 2003 |
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.
Topics: Atrial Fibrillation; Causality; Comorbidity; Homocysteine; Humans; Hyperhomocysteinemia; Risk Assessment; Stroke; Thromboembolism | 2003 |
The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Stroke | 2005 |
Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Echocardiography; Female; Follow-Up Studies; Homocysteine; Humans; Ischemia; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Odds Ratio; Prospective Studies; Regression Analysis; Research Design; Risk; Risk Factors; Stroke; Time Factors; Treatment Failure; Treatment Outcome; Warfarin | 2005 |
Homocysteine inhibits potassium channels in human atrial myocytes.
Topics: Atrial Fibrillation; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Heart Atria; Homocysteine; Humans; In Vitro Techniques; Kinetics; Membrane Potentials; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying | 2007 |
Lipoprotein patterns, plaque, homocysteine, and hormones among ongoing cardiology studies.
Topics: Apolipoproteins E; Atrial Fibrillation; Cardiac Rehabilitation; Cardiology; Cardiovascular Diseases; Depression; Electrocardiography; Estrogens; Female; Homocysteine; Humans; Lipoproteins; Male; Obesity; Risk Factors; Sleep Apnea Syndromes; Tomography, Emission-Computed | 1996 |
Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study.
Topics: Aged; Alzheimer Disease; Arteriosclerosis; Atrial Fibrillation; Brain; Cerebrovascular Circulation; Cognition Disorders; Cross-Sectional Studies; Dementia; Diabetes Mellitus; Female; Homocysteine; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Netherlands; Prospective Studies; Risk Factors; Smoking | 2000 |
Serum homocysteine and stroke in atrial fibrillation.
Topics: Atrial Fibrillation; Homocysteine; Humans; Risk Factors; Stroke | 2001 |